eltroxin levothyroxine sodium 50 microgram tablet bottle
aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 50 microgram - tablet - excipient ingredients: colloidal anhydrous silica; maize starch; purified talc; microcrystalline cellulose; magnesium stearate - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.
eltroxin levothyroxine sodium 175 microgram tablet bottle
aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 175 microgram - tablet - excipient ingredients: magnesium stearate; maize starch; colloidal anhydrous silica; purified talc; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.
eltroxin levothyroxine sodium 200 microgram tablet bottle
aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 200 microgram - tablet - excipient ingredients: purified talc; colloidal anhydrous silica; magnesium stearate; maize starch; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.
eltroxin levothyroxine sodium 88 microgram tablet bottle
aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 88 microgram - tablet - excipient ingredients: colloidal anhydrous silica; maize starch; magnesium stearate; purified talc; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.
eltroxin levothyroxine sodium 150 microgram tablet bottle
aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 150 microgram - tablet - excipient ingredients: purified talc; maize starch; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.
eltroxin levothyroxine sodium 25 microgram tablet bottle
aspen pharmacare australia pty ltd - levothyroxine sodium, quantity: 25 microgram - tablet - excipient ingredients: purified talc; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; pregelatinised maize starch - eltroxin is indicated for the management of demonstrated thyroid hormone deficiency.,eltroxin is also used to suppress thyrotropin (tsh) for the management of tsh-responsive tumours of the thyroid.
furosemide 1%- furosemide syrup
mwi - furosemide (unii: 7lxu5n7zo5) (furosemide - unii:7lxu5n7zo5) - furosemide 10 mg in 1 ml - a diuretic-saluretic for prompt relief of edema. furosemide syrup 1% is an effective diuretic possessing a wide therapeutic range. pharmacologically it promotes the rapid removal of abnormally retained extracellular fluids. the rationale for the efficacious use of diuretic therapy is determined by the clinical pathology producing the edema. furosemide syrup 1% is indicated for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema. the continued usb of heart stimulants, such as digitalis or its glycosides, is indicated in cases of edema involving cardiac insufficiency. furosemide syrup 1% is a highly effective diureticsaluretic which if given in excessive amounts may result in dehydration and electrolyte imbalance. therefore, the dosage and schedule may have to be adjusted to the patients' needs. the animal should be observed for early signs of electrolyte imbalance, and corrective measures administered. early signs of electrolyte im
furoquid
butler animal health supply, llc dba covetrus north america - furosemide (unii: 7lxu5n7zo5) (furosemide - unii:7lxu5n7zo5) - furosemide 10 mg in 1 ml - dog furosemide syrup 1% is an effective diuretic possessing a wide therapeutic range. pharmacologically it promotes the rapid removal of abnormally retained extracellular fluids. the rationale for the efficacious use of diuretic therapy is determined by the clinical pathology producing the edema. furosemide syrup 1% is indicated for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema. the continued usb of heart stimulants, such as digitalis or its glycosides, is indicated in cases of edema involving cardiac insufficiency. furosemide syrup 1% is a highly effective diuretic-saluretic which if given in excessive amounts may result in dehydration and electrolyte imbalance. therefore, the dosage and schedule may have to be adjusted to the patients' needs. the animal should be observed for early signs of electrolyte imbalance, and corrective measures administered. early signs of electrolyte imbalance are: increased thirst, lethargy, dro
furosemide 1%- furosemide syrup
first priority incorporated - furosemide (unii: 7lxu5n7zo5) (furosemide - unii:7lxu5n7zo5) - furosemide 10 mg in 1 ml - a diuretic-saluretic for prompt relief of edema. furosemide syrup 1% is an effective diuretic possessing a wide therapeutic range. pharmacologically it promotes the rapid removal of abnormally retained extracellular fluids. the rationale for the efficacious use of diuretic therapy is determined by the clinical pathology producing the edema. furosemide syrup 1% is indicated for the treatment of edema (pulmonary congestion, ascites) associated with cardiac insufficiency and acute noninflammatory tissue edema. the continued usb of heart stimulants, such as digitalis or its glycosides, is indicated in cases of edema involving cardiac insufficiency. furosemide syrup 1% is a highly effective diureticsaluretic which if given in excessive amounts may result in dehydration and electrolyte imbalance. therefore, the dosage and schedule may have to be adjusted to the patients' needs. the animal should be observed for early signs of electrolyte imbalance, and corrective measures administered. early signs of electrolyte im
ergocalciferol- ergocalciferol capsule
kaiser foundation hospitals - ergocalciferol (unii: vs041h42xc) (ergocalciferol - unii:vs041h42xc) - ergocalciferol 1.25 mg - ergocalciferol capsules, usp are indicated for use in the treatment of hypoparathyroidism, refractory rickets, also known as vitamin d resistant rickets, and familial hypophosphatemia. ergocalciferol capsules, usp are contraindicated in patients with hypercalcemia, malabsorption syndrome, abnormal sensitivity to the toxic effects of vitamin d, and hypervitaminosis d.